BioTrillion

Excited to share another patent granted to BioTrillion! patents.google.com/patent/US12376… It’s been known for centuries that the eyes are windows into the brain. Valuable signals tied to stress, cognition, and #neurology are hidden in tiny pupil responses that have traditionally been too difficult and expensive to quantify—even during annual medical visits. The @BioTrillion solution is a patented method that uses #computervision to quantify pupillary psychosensory responses, transforming subtle eye behavior into objective, trackable #digitalbiomarkers — directly from a selfie video using a simple smartphone (and other/future devices with cameras). Imagine a future where changes in #brain function can be monitored from a simple smartphone scan—opening the door to more accessible #screening, #remotemonitoring, and improved #outcomes for patients, providers, researchers, and industry partners.

@Google expanded @Fitbit with a more personalized AI health coach and medical records integration, bringing consumer tracking and clinical context closer together in one experience. That is a meaningful step toward more connected #DigitalHealth and more useful, context-aware health guidance. @BioTrillion has been building toward this same future from a different direction: software-only, smartphone-based biomarker measurement from a 10 second #HealthySelfie. When visual biomarkers, AI, and personal health context converge, #PreventiveHealth becomes more scalable, more accessible, and far more actionable. blog.google/products-and-p…

@WHOOP’s new $575 million raise at a $10.1 billion valuation shows that investors still see major upside in AI-enabled, continuous health monitoring. The broader message is clear: platforms that turn everyday behavior into longitudinal health insight continue to attract serious attention in #HealthTech and #AI. @BioTrillion sees that same long-term shift through a software-only smartphone lens. While others scale wearables, we are helping push toward a world where a simple 10 second #HealthySelfie can unlock richer biomarker insight, lower friction, and wider access to #PreventiveHealth. wsj.com/articles/whoop…?

In February, @FDA appointed a new leader for its Digital Health Center of Excellence—underscoring how quickly #AI and software-driven healthcare are moving from “innovation” to “regulated reality.” @BioTrillion is building right into that direction: a smartphone-native digital biomarker platform with a clear path toward modular clearances—turning a ~10-second #HealthySelfie into objective “signs” that can scale across payors, providers, and trials. #DigitalHealth #MedTech #HealthAI statnews.com/2026/02/19/fda…

@HLTH argues we’re at a “digital biomarker inflection point,” where infrastructure—validation science, governance, and regulatory pathways—is finally catching up to the tech. That’s exactly the moment @BioTrillion was built for: our ~10-second #HealthySelfie reduces motion/lighting “taint,” boosts repeat usage, and creates cleaner longitudinal baselines—so digital biomarkers can actually work at population scale. #DigitalHealth #AI #RemoteMonitoring #DigitalBiomarkers hlth.com/insights/artic…

@NatureReviewsDrugDiscovery reports wearables are rapidly reshaping #ClinicalTrials—enabling more real-world, participant-friendly monitoring and accelerating the rise of #DigitalBiomarkers as endpoints. @BioTrillion pushes the same trend even further with no new hardware: a ~10-second smartphone scan improves compliance and reduces motion/lighting “taint,” producing cleaner longitudinal baselines for remote endpoints in trials. #Pharma #DCT #HealthAI nature.com/articles/s4157…

A new @Nature analysis highlights the growing business case for adopting #digitalendpoints in #ClinicalTrials—because endpoints drive approval, trial economics, and ultimately payer decisions. @BioTrillion is purpose-built for this shift: device-free digital biomarkers captured from a ~10-second smartphone scan, enabling higher compliance, cleaner real-world signals, and scalable trial participation—without shipping hardware. #DigitalBiomarkers #HealthAI #Pharma nature.com/articles/d4157…

In Consumer Healthcare, the highest priorities aren’t just accuracy—it’s also the user experience. Every second with a user is a privilege. HealthySelfie™ is a ~10-second scan—while other camera-based platforms typically ask users to hold still ~30–60 seconds. A shorter scan is a real advantage: Higher compliance → more people finish the scan, more often Cleaner data → less motion fatigue + fewer lighting/drift artifacts More consistent samples → less chance the environment “taints” the video Better longitudinal baselines → more repeatable check-ins = stronger trend detection Faster workflows → easier to embed in underwriting, telehealth intake, and trials In digital biomarkers, the best model in the world can’t help if users don’t complete the scan. Imagine when health-checks go from 1x per year to each time you unlock your phone: FaceID => HealthID 🚀 #DigitalHealth #DigitalBiomarkers #InsurTech #HealthAI

@Cadence is joining @CMS and @CMMI’s new Medicare chronic care experiment, @ACCESS, where providers are paid fixed amounts tied to whether patients’ chronic conditions improve, rather than purely fee-for-service RPM billing. The article highlights how this model pressures care teams to use automation and smarter monitoring to deliver outcomes at lower labor cost. This is exactly where @BioTrillion fits: a 10-second hashtag#HealthySelfie scan creates objective, repeatable hashtag#DigitalBiomarkers without wearables, so programs can scale measurement while reducing device logistics and staff burden. As outcomes-based RPM grows, low-friction signal capture plus quality scoring becomes the difference between a dashboard and an actual care workflow. hashtag#RemotePatientMonitoring hashtag#DigitalHealth hashtag#AIinHealthcare statnews.com/2026/03/09/rem…

@MindsetMedical’s Vital-Trac shows how #DigitalHealth is collapsing the “clinic-only vitals” bottleneck: the company uses #rPPG with standard cameras to measure vitals without physical contact, and reports @FDA clearance to measure pulse and respiratory rate. @BioTrillion is built on the same “camera as clinical window” shift, but extends it into 10 head-to-toe #DigitalBiomarkers (ocular + cardio/neuro signals like heart rate, tremor, and gait cues) from a ~10-second #HealthySelfie scan—so measurement can scale across #Telehealth, trials, and insurance without new hardware. news.asu.edu/20260114-healt…

@NeuraLight and @TeiturTrophics announced a collaboration to use precision brain-function biomarkers (derived from eye movements) in Teitur’s upcoming TT-P34 #Parkinsons clinical trial—making neural pathway function more objectively measurable. #ClinicalTrials #Neurology #DigitalBiomarkers That “objective brain function at scale” thesis maps tightly to @BioTrillion: HealthySelfie uses the smartphone camera as a clinical observation window to capture neuro + cardio biomarkers (including ocular signals) without wearables. When trials can measure function remotely, endpoints get richer and participation gets easier. #AIinHealthcare #DecentralizedTrials businesswire.com/news/home/2026…

@FDA continues expanding its public list of authorized sensor-based digital health tech devices—highlighting how quickly biomarker-like features (e.g., @Apple’s hypertension notification feature) are moving into formal oversight pathways. This trend strengthens the case for software-native measurement (including camera-based): standardize validation, report reliability, and then use those signals for #ClinicalTrials, longitudinal tracking, and consumer wellness—exactly the runway @BioTrillion is building on. #AI #DigitalHealth fda.gov/medical-device…

@FDA and @EMA have outlined shared “good AI practice” principles for AI used across the drug lifecycle—emphasizing validation, transparency, traceability, and ongoing monitoring so AI outputs can actually be trusted in regulated decision-making. That’s the direction @BioTrillion is built for: turning a 10-second smartphone scan into auditable digital biomarkers that can plug into #ClinicalTrials and #DrugDevelopment with cleaner data governance—not black-box vibes. #AIinHealthcare #DigitalBiomarkers #DigitalHealth reuters.com/business/healt…

androidcentral.com/wearables/ultr… @Ultrahuman and @Click Therapeutics are launching “Migraine PowerPlug,” combining ring-derived biomarker analytics (e.g., HRV, stress, sleep) with a digital therapeutic approach to help users spot patterns and manage migraines in real time. The bigger story: predictive care is moving from episodic check-ins to continuous signals—exactly why @BioTrillion focuses on turning a quick #smartphone scan into actionable digital biomarkers without requiring wearables. #Migraine #Wearables #DigitalHealth #AI

businesswire.com/news/home/2026… This is the playbook: trials and care pathways are shifting from episodic clinic snapshots to high-frequency digital measurement. @BioTrillion is building toward the same endpoint—using a ubiquitous smartphone scan to capture ocular + motor digital biomarkers (tremor/gait cues) that can support #ClinicalTrials, remote endpoints, and earlier signal detection. #DigitalBiomarkers #Neurology

@CES 2026 recognized @BioConnect’s VitalTracker/VitalPlatform for using camera-based rPPG to estimate multiple vital signs (including HR, RR, SpO₂, and estimated blood pressure) without contact—turning “look at the camera” into a measurement moment. That’s exactly the direction @BioTrillion is betting on: a practical “check engine light” for humans, where #AI + computer vision turns a 10-second selfie into repeatable cardio/neuro biomarker signals that can plug into telehealth workflows and large-scale screening. #HealthTech #Telehealth #ComputerVision #DigitalBiomarkers ces.tech/ces-innovation…

@Ultrahuman and @ClickTherapeutics announced “Migraine PowerPlug,” combining biomarker-based insights with guided behavioral interventions, built on the technology behind @ClickTherapeutics’ FDA-authorized digital therapeutic (CT-132) for episodic migraine. This is a clean validation of a bigger theme: software can turn everyday signals into actionable care—@BioTrillion’s #HealthySelfie applies that playbook across neuro + cardio by extracting multiple head-to-toe biomarkers from the phone camera in 10 seconds, with no wearables. #DigitalHealth #ClinicalAI #RemoteMonitoring #Migraine hitconsultant.net/2026/01/14/hea…

The UK just launched the world’s first smartphone-based HbA1c test for type 2 diabetes—delivering instant results from a finger-prick scan using a smartphone camera. As reported by @TheSun , it could help prevent thousands of heart attacks and strokes through earlier detection. At @BioTrillion , we’re excited to see national health systems align with the direction we’ve pioneered. Our #HealthySelfie platform enables contactless measurement of 10 vital signs and digital biomarkers—from pupil reflex to heart rate—using just a smartphone video. No needles, no wearables, no new hardware. Source: thesun.co.uk/health/3638332… #DigitalBiomarkers #AIinHealthcare #MobileHealth #RemotePatientMonitoring #HealthySelfie #BioTrillion #PreventionFirst #HealthTech #FutureOfHealthcare